Immunotherapy reverses glioma-driven dysfunction of immune system homeostasis

BACKGROUND: Glioma-induced immune dysregulation of the hematopoietic system has been described in a limited number of studies. In this study, our group further demonstrates that gliomas interrupt the cellular differentiation programming and outcomes of hematopoietic stem and progenitor cells (HSPCs)...

Descripción completa

Detalles Bibliográficos
Autores principales: DiVita Dean, Bayli, Wildes, Tyler, Dean, Joseph, Yegorov, Oleg, Yang, Changlin, Shin, David, Francis, Connor, Figg, John W, Sebastian, Mathew, Font, Laura Falceto, Jin, Dan, Reid, Alexandra, Moore, Ginger, Fernandez, Brandon, Wummer, Brandon, Kuizon, Carmelle, Mitchell, Duane, Flores, Catherine T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906384/
https://www.ncbi.nlm.nih.gov/pubmed/36750252
http://dx.doi.org/10.1136/jitc-2022-004805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906384/
https://www.ncbi.nlm.nih.gov/pubmed/36750252
http://dx.doi.org/10.1136/jitc-2022-004805

Ejemplares similares